CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...

Mogłam nie spać i nie jeść, pracując na pełnych obrotach przez całą dobę" — opowiada Ania, która zmaga się z chorobą afektywną dwubiegunową. Jak jednak mówi, to, co przyszło później, przekreślało ...

Laureaci muzycznej nagrody "Niebieski Mikrofon" - Ania Karolska i raper Maxim - ponownie w Polskim Radiu Białystok. W czwartek wieczorem (5.06) zaprezentowaliśmy ich premierowe nagrania inspirowane ...

Auditory abnormal sensations encompass various subjective auditory symptoms such as tinnitus, hyperacusis, aural fullness, autophony, dysacusis, pseudo-hallucinations, and misophonia. Although ...

Introduction: Misophonia is a recently described, poorly understood and neglected condition. It is characterized by strong negative reactions of hatred, anger or fear when subjects have to face some ...

2025). A Phase 2 human trial led by Jastreboff et al. (2023) demonstrated up to 24.2% weight loss in non-diabetic obese participants, along with significant improvements in blood pressure ...

Note: This press release has been altered from its original version to correct the citations that appear in the fifth paragraph. Four leading organizations in lifestyle medicine, obesity medicine ...

Diabetes mellitus (DM), a metabolic disorder syndrome characterized by persistent hyperglycemia, has a complex pathogenesis. As the number of diabetic patients continues to grow globally, this disease ...

Orforglipron (or-for-GLIP-ron) is an investigational, once-daily small molecule (non-peptide) oral glucagon-like peptide-1 (GLP-1) receptor agonist that can be taken any time of the day without ...

1 Department of Endocrinology and Diabetology, Clinic of Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia 2 Faculty of Medicine, University of Maribor, Maribor, Slovenia ...